TEVA (TEVA)
Teva Pharmaceutical Industries Ltd. - Teva toAcquire Emalex Biosciences, Adding NDA-Ready, First-in-Class Therapy to Neuroscience Pipeline and AcceleratingTeva’s Pivot to Growth Strategy
Teva Pharmaceutical Industries Ltd. - Teva toAcquire Emalex Biosciences, Adding NDA-Ready, First-in-Class Therapy to Neuroscience Pipeline and AcceleratingTeva’s Pivot to Growth Strategy
PROSPERITY BANCSHARES, INC.® REPORTS FIRST QUARTER 2026 EARNINGS
Delek US Holdings Reports First Quarter 2026 Results
Teva to Acquire Emalex Biosciences, Adding NDA-Ready, First-in-Class Therapy to Neuroscience Pipeline and Accelerating Teva’s Pivot to Growth Strategy
Babcock & Wilcox Secures $21 Million for Fuel Switching Technology Awards; Parts and Services Continues Strong Performance Driven by Increased Baseload Demand
SOLAI Limited Announces Changes to Board of Directors
Parsons Reports First Quarter 2026 Results
Quarterly Activities and Cashflow Report - March 2026
Central Pacific Financial Reports First Quarter 2026 Earnings of $20.7 Million
Delek Logistics Reports First Quarter 2026 Results